BlackRock, Inc. 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BlackRock Inc. BLK |
8,453,014 8.200% |
-557,681 (-6.19%) |
Filing |
| 2024-01-08 4:35 pm Purchase |
2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BlackRock Inc. BLK |
9,010,695 10.100% |
1,755,774 (+24.20%) |
Filing |
| 2023-01-25 10:36 am Purchase |
2022-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BlackRock Inc. BLK |
7,254,921 8.700% |
1,634,545 (+29.08%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BlackRock Inc. BLK |
5,620,376 7.600% |
567,531 (+11.23%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BlackRock Inc. BLK |
5,052,845 8.600% |
1,407,615 (+38.62%) |
Filing |